H
Hirokazu Hirata
Researcher at Kyoto University
Publications - 10
Citations - 800
Hirokazu Hirata is an academic researcher from Kyoto University. The author has contributed to research in topics: Apoptosis & Cyclophosphamide. The author has an hindex of 6, co-authored 9 publications receiving 784 citations.
Papers
More filters
Journal ArticleDOI
Caspases are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis
Hirokazu Hirata,Atsushi Takahashi,Susumu Kobayashi,Shin Yonehara,Hirofumi Sawai,Toshiro Okazaki,Kokichi Yamamoto,Masataka Sasada +7 more
TL;DR: It is demonstrated that caspases are organized in a protease cascade, and that each activated caspase plays a distinct role(s) in the execution of Fas-induced cell death.
Journal ArticleDOI
Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production
Kouhei Yamashita,Atsushi Takahashi,Susumu Kobayashi,Hirokazu Hirata,Peter W. Mesner,Scott H. Kaufmann,Shin Yonehara,Kokichi Yamamoto,Takashi Uchiyama,Masataka Sasada +9 more
TL;DR: Observations suggest that a caspase cascade mediates apoptotic events and downregulates oxygen radical production in TNF-–treated neutrophils, and raise the possibility that suppression of caspases in neutrophil apoptosis with enhanced proinflammatory actions of TNP may underlie the pathogenesis of inflammatory diseases.
Journal ArticleDOI
Affinity labeling displays the stepwise activation of ICE-related proteases by Fas, staurosporine, and CrmA-sensitive caspase-8
Atsushi Takahashi,Hirokazu Hirata,Shin Yonehara,Yuzuru Imai,Kyung-Kwon Lee,Richard W. Moyer,Peter C. Turner,Peter W. Mesner,Toshiro Okazaki,Hirofumi Sawai,Shuji Kishi,Kokichi Yamamoto,Minoru Okuma,Masataka Sasada +13 more
TL;DR: Findings provide evidence that caspase-8, a CrmA-sensitive protease, is responsible for initiating the stepwise activation of multiple caspases in Fas-stimulated cells.
Journal ArticleDOI
Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Yoshinobu Konishi,Satoshi Takahashi,Katsuyuki Nishi,Taro Sakamaki,Sachiko Mitani,Hitomi Kaneko,Chisato Mizutani,Naoya Ukyo,Hirokazu Hirata,Mitsuru Tsudo +9 more
TL;DR: The experience of a unique case of TAFRO syndrome in a 78-year-old woman whose symptoms responded differently to several therapies is presented, providing insight into the possible role of interleukin-2, in addition to interleucin-6, in TAF RO syndrome.
Journal ArticleDOI
Lenalidomide and low‐dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study
Kenshi Suzuki,Atsushi Shinagawa,Toshiki Uchida,Masafumi Taniwaki,Hirokazu Hirata,Kenichi Ishizawa,Kosei Matsue,Yoshiaki Ogawa,Takayuki Shimizu,Maki Otsuka,Morio Matsumoto,Shinsuke Iida,Yasuhito Terui,Itaru Matsumura,Takashi Ikeda,Naoki Takezako,Yumi Ogaki,Shuichi Midorikawa,Vanessa Houck,Annette Ervin-Haynes,Takaaki Chou +20 more
TL;DR: The efficacy and safety of Rd were consistent with data from larger studies, including the FIRST trial, thereby supporting the use of Rd continuous in Japanese patients with NDMM who are ineligible for stem cell transplantation.